Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Warts 12Keratosis, Actinic 12Breast Neoplasms 11Prostatic Neoplasms 10Uterine Cervical Dysplasia 7Retinoblastoma 7Peripheral Nervous System Diseases 6Pain 6Neoplasm Metastasis 6Lung Neoplasms 6Neoplasms 5Stomatitis 4Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Mucositis 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Stomach Neoplasms 2Papillomavirus Infections 2Multiple Myeloma 2Mesothelioma 2Melanoma 2Keratosis 2Deglutition Disorders 2Condylomata Acuminata 2Carcinoma, Ductal, Breast 2Carcinoma, Basal Cell 2Bone Neoplasms 2Barrett Esophagus 2

Interventions

aldesleukin 43Sunitinib 42Cyclophosphamide 30Nivolumab 29pembrolizumab 27Everolimus 27Interferon-alpha 25Bevacizumab 23Sorafenib 22Interleukin-2 20fludarabine phosphate 19Radiotherapy 18Ipilimumab 18Filgrastim 18Axitinib 18Gene Expression Profiling 16Peripheral Blood Stem Cell Transplantation 15Gemcitabine 15cabozantinib 14Radiosurgery 13fludarabine 11Doxorubicin 11Carboplatin 11Blood Specimen Collection 11temsirolimus 10atezolizumab 9Immunohistochemistry 9Etoposide 9Chemotherapy, Adjuvant 9sargramostim 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Cryotherapy × Clear all
NCT03540199 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2 Withdrawn
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡